We are proud to announce the launch of Gnomica Biotherapy, a new biotech company emerging from discoveries made in Ravid Straussman's lab at the Weizmann Institute of Science!

Gnomica is pioneering a novel approach to cancer treatment, developing small-molecule drug inhibitors targeting bacterial functions in the human body, a critical and often overlooked factor in treatment resistance.

Quantum Art to Advance Scalable Quantum Computing Through Logical Qubit Compiler and NVIDIA CUDA-Q Integration

The latest advancements in quantum computing, including a new logical qubit compiler and integration with NVIDIA CUDA-Q, are set to significantly boost the scalability of quantum systems.

This is a huge leap forward for the industry, paving the way for more powerful and accessible quantum solutions.

UltraSight™ Receives KFDA Regulatory Approval for AI Guidance System, Expanding Global Access to Cardiac Imaging

Biotech start-ups Phytolon and Ginkgo Bioworks have announced the successful completion of the second development milestone in their multi-product collaboration to produce natural food colours.

Weight loss is a serious issue amongst Americans. While obesity is the main condition related to this issue, weight loss is also a major concern for many patients. It’s not uncommon for people to lose weight either directly from being sick or as a side effect of medication.

UltraSight, a spinoff company of Yeda, Expands Access to Echocardiographic Monitoring for Obstructive Hypertrophic Cardiomyopathy Patients
“By applying the power of machine learning to imaging, our aim is to streamline patient cardiac workflows for better, more efficient, and effective care” (Davidi Vortman, CEO)